Skip to main content
. Author manuscript; available in PMC: 2021 Sep 28.
Published in final edited form as: Mol Psychiatry. 2016 Jul 26;22(2):321–322. doi: 10.1038/mp.2016.126

Table 1.

Nine of the 1000 SNPs with the lowest P-values in a GWAS for AN risk (GCAN9) are associated with decreased BMI (GIANT11, with Bonferroni-corrected P < 0.05 significance; sorted according to the nominal P-values for BMI in all GIANT participants)

Chromosome/position/SNP nearest gene(s) Location Rank in AN GWAS AN reference allele/frequency in AN cases Odds ratio (s.e.m.) for AN reference allele P-value for AN risk BMI reference allele/frequency in GIANT β (s.e.m.) for BMI reference allele Nominal P-value for BMI: all female/male Bonferroni corrected P-valuea Direction of effect (+/−)b
10/126685663
rs1561589
CTBP2
Intron 201 G/0.67 1.14 (0.04) 7.74 × 10−5 G/0.66 −0.0157 (0.0033) 2.47 × 10−6
3.45 × 10−7/0.043
0.0025 +
10/126681170
rs12771627
CTBP2
Intron 190 A/0.25 0.87 (0.03) 7.28 × 10−5 A/0.26 0.0162 (0.0035) 4.25 × 10−6
5.8 × 10−6/0.022
0.0043 +
10/126674064
rs11245456
CTBP2
Intron 177 G/0.25 0.87 (0.03) 6.79 × 10−5 G/0.25 0.0171 (0.0037) 4.58 × 10−6
1.03 × 10−5/0.009
0.0046 +
19/34978662
rs17513613
CCNE1
Distant 5′ 409 C/0.30 0.88 (0.03) 0.0002 C/0.33 0.015 (0.0033) 5.41 × 10−6
6.4 × 10−3/1.24 × 10−5
0.0054 +
2/203492447
rs17406900
CARF
Intron 709 G/0.52 0.90 (0.03) 0.0003 G/0.51 0.0134 (0.0031) 1.08 × 10−5
1.8 × 10−4/2.27 × 10−3
0.0108 +
2/203639257
rs7593917
NBEAL1
Intron 444 G/0.54 0.89 (0.03) 0.0002 G/0.54 0.0131 (0.0031) 2.48 × 10−5
9.54 × 10−5/9.39 × 10−3
0.0248 +
2/203582157
rs11691351
NBEAL1
Distant 5′ 412 G/0.54 0.89 (0.03) 0.0002 G/0.54 0.0126 (0.0031) 3.57 × 10−5
1.98 × 10−4/8.21 × 10−3
0.0357 +
19/34988693
rs8102137
CCNE1
Distant 5′ 248 C/0.30 0.88 (0.03) 9.45 × 10− 5 C/0.33 0.0169 (0.0041) 3.76 × 10−5
0.006/2.46 × 10−4
0.0376 +
2/203635796
rs7573079
NBEAL1
Intron 401 A/0.54 0.89 (0.03) 0.0002 A/0.54 0.0124 (0.0031) 4.61 × 10−5
2.80 × 10−4/0.008
0.0461 +

Abbreviations: AN, anorexia nervosa; BMI, body mass index; CARF, calcium-responsive transcription factor; CCNE1, cyclin E1; CTBP2, C-terminal binding protein 2; GCAN, Genetic Consortium for AN; GIANT, Genetic Investigation of ANthropometric Traits; GWAS, genome-wide association studies; NBEAL1, neurobeach inlike 1, SNP, single-nucleotide polymorphism.

a

Primary analysis, sex-combined, correction for 1000 test.

b

Direction of effect: ‘+’ the effect/risk allele for decreased BMI and AN risk are identical.